Skip to content

Real world research protocol for the application of Teneprase in acute ischemic stroke

Real world research protocol for the application of Teneprase in acute ischemic stroke

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096121
Enrollment
Unknown
Registered
2025-01-17
Start date
2024-11-21
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

Thrombolysis group:None
Non thrombolytic group:None

Sponsors

Suzhou Hospital Affiliated to Nanjing University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Age>=18 years; (2) Confirmed acute ischemic stroke; (3) Meet the criteria for intravenous thrombolytic therapy in the 2023 edition of the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke; (4) Arrive at the hospital within 4.5 hours after the onset of symptoms; (5) Subject or guardian signs informed consent.

Exclusion criteria

Exclusion criteria: (1) History of major head trauma or stroke in the past 3 months; (2) Intracranial hemorrhage (including parenchymal hemorrhage, intraventricular hemorrhage, subarachnoid hemorrhage, subdural/extradural hematoma, etc.); (3) Arterial puncture of the site that is not easy to compress in the past 1 week; (4) History of previous intracranial hemorrhage; (5) Intracranial tumors, intracranial giant aneurysms; (6) Intracranial or neuraxial surgery in the past 3 months; (7) Major surgery in the past 2 weeks; (8) aortic arch dissection; (9) Active visceral hemorrhage.

Design outcomes

Primary

MeasureTime frame
Proportion of modified Rankin Scale (mRS) score <=2 (functional Recovering well);

Secondary

MeasureTime frame
90-day distribution of mRS score values;Exacerbation within 24 hours (elevated NIHSS >=4 points);Patient mRS score at discharge;Comparison of the effectiveness of the thrombolysis group with other thrombolysis databases in the same period;

Countries

China

Contacts

Public ContactJingwei Li

Department of Neurology, Suzhou Hospital Affiliated to Nanjing University School of Medicine

ljw323@yeah.net+86 136 7515 8558

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026